Back to COGT
Candriam S.C.A. COGT Position History
Cogent Biosciences, Inc. • Healthcare
Quarters held
6
Latest value
$63M
Q3 2026
Peak value
$80.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $13.7M |
| Q4 2025 | $46.1M |
| Q4 2025 | $46.1M |
| Q1 2026 | $58.4M |
| Q2 2026 | $80.7M |
| Q3 2026 | $63M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $63M | 1.96M | — | — |
| Q2 2026 | $80.7M | 2.09M | — | — |
| Q1 2026 | $58.4M | 1.52M | — | — |
| Q4 2025 | $46.1M | 1.30M | — | — |
| Q4 2025 | $46.1M | 1.30M | — | — |
| Q3 2025 | $13.7M | 954.2K | — | — |
Other funds holding COGT
$868.7M
$808M
$756M
$706.8M